Home monitoring to help prevent hospital stays for ATTR heart disease
Part of Brain & nervous system, Genetic & congenital, Hormones & metabolism clinical trials.
This trial tests whether using home weight/health tracking can help people with ATTR cardiomyopathy avoid going to the hospital. It may help by catching fluid build-up or worsening earlier so treatment can be adjusted sooner.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re 18 or older and can sign consent at the start of screening
- You have a confirmed diagnosis of ATTR cardiomyopathy
- You can understand the study and follow its rules and visits
- You currently receive care at one of the study sites
- You can use the BodyTrace home scale where you live (including needing a working mobile network signal)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an eHealth support system designed to help people with ATTR amyloidosis (a type of heart disease) who have had a recent heart failure episode. It aims to improve care and follow-up for people with this condition.
This trial tests whether checking in remotely (telemonitoring) helps doctors adjust heart failure medications more effectively. It is for people newly diagnosed with heart failure who have reduced pumping strength and signs of fluid buildup.
This trial uses heart scans to see how the drug acoramidis affects heart structure and function in people with a specific type of heart disease called ATTR cardiomyopathy. It may help doctors understand if the treatment is working.
This study tests whether a wearable device that monitors your heart and transmits data to your doctor can help optimize your heart failure medications after hospitalization. The goal is to prevent future hospital visits and improve your health by keeping closer tabs on how your body responds to treatment adjustments.
This trial checks whether using a smartphone or tablet to monitor heart failure symptoms from home is feasible and helps people do better. You may be asked to track your symptoms and health data, and the team will see if this approach can work safely.
This trial tests a new medicine called Coramitug for people with heart failure due to ATTR amyloidosis, a condition where abnormal proteins build up in the heart. The study aims to see if Coramitug can improve heart function and quality of life.
Hear when a new Cardiac Amyloidosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.